Hypertension is a leading cause of disease burden and mortality. Here, we present a single-cell analysis of hypertension and end-organ damage across six organs and tissues in angiotensin II-treated mice, Dahl salt-sensitive rats, and spontaneously hypertensive rats. We identified gene programs associated with blood pressure and renal injury, including a conserved vascular smooth muscle cell program and cross-segment renal tubular programs, along with tissue-specialized endothelial adaptations and coordinated changes across cell types in select organs. Integration with human genomic data revealed model-specific and shared cell type-trait links. We prioritized a noncoding variant (rs28451064) and used genome editing to demonstrate its in vivo effect on blood pressure and allele-specific regulation of local genes. Our study provides a multimodel, cross-organ cellular resource for hypertension research.

Direct targeting of noncoding genomic regions harboring common sequence variants associated with human traits through in vivo animal model studies and precise genome editing in human cells is essential for closing the critical gap between genetic discoveries and physiological understanding. However, such investigation has been impractical for many of these variants as they are in haplotypes containing multiple single-nucleotide polymorphisms (SNPs) spanning thousands of base pairs and have small effect sizes. We developed an integrated approach to address this challenge, combining an efficient two-step technique to precisely edit large haplotypes in human induced pluripotent stem cells and orthologous region deletion in phenotypically permissive animal models. As proof of principle, we applied this approach to examine a blood pressure-associated locus with a noncoding haplotype containing 11 SNPs spanning 17.4 kbp. We found a robust blood pressure effect of nearly 10 mmHg and identified the physiological and molecular mechanisms involved.

Arterioles are small blood vessels located just upstream of capillaries in nearly all tissues. Despite the broad and essential role of arterioles in physiology and disease, current knowledge of the functional genomics of arterioles is largely absent. Here, we report extensive maps of chromatin interactions, single-cell expression, and other molecular features in human arterioles and uncover mechanisms linking human genetic variants to gene expression in vascular cells and the development of hypertension. Compared to large arteries, arterioles exhibited a higher proportion of pericytes which were enriched for blood pressure (BP)-associated genes. BP-associated single nucleotide polymorphisms (SNPs) were enriched in chromatin interaction regions in arterioles. We linked BP-associated noncoding SNP rs1882961 to gene expression through long-range chromatin contacts and revealed remarkable effects of a 4-bp noncoding genomic segment on hypertension in vivo. We anticipate that our data and findings will advance the study of the numerous diseases involving arterioles.

Background: The understanding of genetic and epigenetic regulation of gene expression in endothelial and vascular smooth muscle cells remains fragmented with limited experimental validation. Methods: Chromatin conformation (Micro-C), DNA methylation (RRBS), chromatin accessibility (ATAC-seq), and transcriptome profiles (RNA-seq) were mapped in human induced pluripotent stem cell (hiPSC)-derived, isogenic endothelial and vascular smooth muscle cells (iECs and iVSMCs). CTCF and RAD21 were depleted to assess the functional relevance of chromatin architecture, and genome editing was used to evaluate the allelic effect of a blood pressure-associated single nucleotide polymorphism (SNP). Results: Significant correlations were identified between gene expression levels and chromatin interactions, chromatin accessibility, and DNA methylation in iECs and iVSMCs, with chromatin interactions showing the strongest association. Chromatin contact regions displayed distinct epigenetic landscapes depending on the types of regulatory element interactions involved. Perturbation of CTCF and RAD21 revealed their differential regulatory effects, particularly on the expression of genes overlapping chromatin contacts, with RAD21 exhibiting a broader regulatory impact. SNPs associated with several vascular traits were enriched in chromatin loops or accessible regions in iECs or iVSMCs. Precise genome editing demonstrated allele-dependent effects of SNP rs9833313 on the expression of SHOX2 located 247.4 kbp away but within the same chromatin loops as the SNP. Conclusion: This study provides an extensive epigenetic landscape of vascular cells that may drive novel research on the role of genetic and epigenetic mechanisms of vascular function and disease as demonstrated by our targeted experiments. ### Competing Interest Statement The authors have declared no competing interest.

Changes in chromatin conformation caused by common genetic variations may impact blood pressure regulation and hypertension risk. A major function of CCCTCF-binding factor (CTCF) is to bind to DNA to regulate and maintain chromatin conformation, and thereby gene expression. Cellular expression of CTCF is critical for proper Renin expression and the Renin gene is surrounded by multiple CTCF-binding motifs . In the Dahl salt-sensitive (SS) rat, CRISPR-Cas9 was utilized to create three models harboring mutations to the CTCF motif surrounding the Renin gene. CTCF binding was confirmed to be disrupted in all three models. The mutants and wild-type (WT) littermates were then placed on a 0.1%, 4.0% or maintained on a 0.4% NaCl diet for four days, and Renin mRNA and plasma renin activity (PRA) was examined. mRNA analysis showed no differences in Renin expression on any diet for any model compared to WT. Interestingly, two of our male mutant models failed to increase their PRA on the 0.1% NaCl diet (CTCF1=13.87±0.86; CTCF2=13.95±0.59; p<0.05 compared to WT=17.52±0.81 on 0.1% NaCl). We hypothesized that Renin dynamic transcriptional response to salt depletion is delayed in the mutant models compared to WT. To test this, we have utilized an ex vivo kidney slice culture approach. Kidneys were excised from SS rats fed a 4.0% NaCl diet for 1-2 days, sliced to ~1-3 mms, and cultured for 24 hrs. Renin expression was evaluated at 0, 1, 2, 4, 8, 12, 16, 20 and 24 hrs of incubation in basal media. Renin expression was elevated in SS rats at 8 hrs (3.82±0.38 compared to 0 hr = 0.93±0.32) and continued to increase until 12 hrs (7.05±1.87) and reduced at 16 hrs (1.42±0.70). CTCF1 mutant Renin expression was significantly reduced at 12 hrs (3.77±0.58 compared to WT=7.05±1.87), while CTCF2 mutants showed no differences in Renin expression compared to WT. Thus, we established an ex vivo approach for monitoring the dynamic changes in Renin expression by culturing kidney slices. This method could be used to evaluate other stimuli, such as therapeutics.

GWAS has identified >1,000 blood pressure (BP)-associated sentinel SNPs, most of which (>90%) are intronic and intergenic. How they regulate BP-relevant genes remains an open question. We hypothesized many SNPs would reside within cis -regulatory elements specific to nephron segments critical to sodium resorption such as proximal tubule (PT) and thick ascending limb (TAL). To address this, we developed chromatin state (ATAC-seq) and transcriptome (RNA-seq) maps from manually dissected human PT and medullary TAL (mTAL) segments. We identified 216,168 and 179,467 open regions in PT and mTAL, respectively, with the majority (70%) being unique to one tissue. Interestingly, peaks shared between the two segments resided more frequently in promoters, whereas unique peaks were more often found in distal introns or intergenic regions, suggesting they lie within enhancers ( Figure 1A ). Both chromatin state and transcriptomic data demonstrated a correlation between open chromatin peaks within gene promoters and mRNA levels (r=0.11; p<4.6e-16). This correlation was weaker at open regions distal to the promoter, illustrating the difficulty of mapping distal open regions to the gene(s) they regulate. We hypothesized these open regions would be enriched for BP-relevant SNPs. We curated 1,071 bp-associated SNPs and found 87 and 67 in mTAL and PT, open regions respectively, many of which are near BP-relevant genes. This enrichment was significant based on 10 4 randomizations (pValue 10 -4 ) ( Figure 1B ). We conclude that these novel tissue-specific chromatin maps can be used to identify potential mechanisms by which SNPs influence gene expression and BP. Additional studies will be needed to demonstrate both causality and molecular mechanisms.

The kidney plays a crucial role in the onset and progression of hypertension. To investigate the roles of different renal cell types in hypertension, we applied single-nucleus sequencing and spatial transcriptome sequencing to kidney samples from three well-established hypertension models: C57BL/6 mice treated with Ang II, the Dahl salt-sensitive (SS) rat on high-salt diets, and the spontaneously hypertensive rat (SHR), along with their respective controls including Sprague-Dawley (SD) and Wistar Kyoto (WKY) rats. Our dataset comprised 179,637 nuclei from 24 samples across 12 experimental conditions, identifying 17 major cell types including various epithelial cells, endothelial cells, vascular smooth muscle cells, fibroblasts, and immune cells. At baseline, differentially expressed genes between the SS and SD groups were specifically enriched in endothelial cell pathways related to vascular development. This included expression deficiencies in genes involved in angiogenesis in SS rats, such as Arhgap24 and Nox4. Compensatory expression changes in these genes were observed in the SS rats after a high-salt diet and in 26-week-old SHR, but not in their respective controls. These genes were also associated with multiple blood pressure-associated single-nucleotide polymorphisms (SNPs). Furthermore, changes in endothelial cell communication were most prominent upon stimuli, with impaired PTPRM (Protein Tyrosine Phosphatase Receptor Type M) signaling being a robust feature in hypertension models, involving angiogenic endothelial cells in the SS model and proliferating capillary endothelial cells in the SHR model. Our study highlights the critical role of renal endothelial cell angiogenic dysfunction in the pathogenesis of hypertension and suggests a link between specific renal endothelial cell subtype dysregulation and hypertension development.

Many non-coding SNPs identified in Genome-Wide Association Studies (GWAS) likely affect BP-related gene expression through epigenetic mechanisms. This study analyzes the comparative genomic and epigenomic landscapes in human and rat kidney tissues, including kidney proximal tubule (PT) and medullary thick ascending limb (mTAL), focusing on the major challenge of identifying conserved regulatory elements in intergenic regions. The purpose of our study is to identify BP gene regulatory elements in intergenic regions that are conserved from human to rat for in vivo validation and mechanistic studies. Our ultimate goal is to generate high-resolution, genome-wide epigenomic maps of key BP-relevant tissues, using ATAC-seq, Hi-C, CUT&Tag, DNA methylation profiling and RNA-seq. We are creating visualization hubs for human and rat, integrating our data within the UCSC Genome Browser environment. UCSC contains extensive data for humans but very little for rats, particularly for the updated genome assemblies. To address this gap, we integrated our results with data from the Rat Genome Database (RGD). To date, we harmonized ATAC-seq data from human and rat PT and mTAL and displayed these data in RGD’s JBrowse2 genome browser for unique comparative genome views. Based on our initial analysis of data density and intensity, we are developing a novel pattern recognition algorithm to identify epigenomic marks that are conserved across rat and human genomes. Existing algorithms predominantly focus on the conservation of coding genes, gene families, and genomic sequences. Here, average normalized peak intensities for ATAC-seq data across tissues were subject to canonical correlation between human and rat to identify conserved epigenomic patterns within the BP GWAS loci. Here we present an example of a human BP locus in the intergenic region between NPR3 and TARS1 on chromosome 5 which has a region of conserved synteny with rat chromosome 2. Comparative analysis and visualization of this region show significant correlation between ATAC-seq peaks from rat and human PT and mTAL at this locus, with predicted conserved regulatory elements. These visualizations can uncover novel biological insights and identify potential regulatory targets for intervention. This work underscores the importance of advanced visualization techniques in understanding hypertension pathogenesis, facilitating cross-species comparisons, and enhancing the utility of genomic databases.

Introduction: The progression of renal pathology in autosomal dominant polycystic kidney disease (ADPKD) involves a complex series of changes including renal cyst formation, interstitial cyst expansion, tubular atrophy, and fibrosis. Changes to in tissue metabolism and cyst fluid metabolite composition have been shown in ADPKD models, however it has been diffcult to discretely localize these compounds to specific regions of the kidney. Further, very little is known about lipid profiles within the kidney during ADPKD. We hypothesized that spatial lipidomic analysis during periods of cyst expansion would reveal new understanding of changes in lipid metabolism during this critical window of pathology. In this study we focused on changes in the mcwPkd1nl/nl mouse, a hypomorphic ADPKD model that rapidly develops a cystic phenotype. Methods: Kidneys were collected from female cystic mcwPkd1nl/nl mice at postnatal days 7, 14 and 28, representing periods preceding, during and at maximal cyst expansion, respectively. Control kidneys were collected from female wild-type littermates at postnatal day 7 and 28. Tissues were rapidly cryoembedded for 10 mm sectioning onto Intellislides (BrukerDaltonik). Slides were scanned on a Reflecta MF-5000 scanner and sprayed with 7 mg/mL CHCA in 70% Acetonitrile, 30% water and 0.1% TFA using a TM Sprayer Model M3 (HTX Technologies, LLC). Mass spec imaging data was acquired with a Bruker timsTOF Flex system (BrukerDaltonik) with a Smartbeam 3D laser at 10kHz and 10 μm resolution. Imaging data analysis was performed in SCiLS Lab software (version 2023b, Bruker). Calculations were performed on data normalized to total ion count (TIC). Spatial segmentation analysis of data was performed using an unsupervised bisecting k-means algorithm and resulting clusters were investigated by ROC. Lipid annotation was performed the Lipid Species annotation tool with MSDial VS68 spectral library in Metaboscape (version 2022b, Bruker). Results: There were vast global differences between lipid composition of wild-type and cystic kidneys at postnatal day 28. When comparing cystic to wild-type kidneys phosphoinositol and ceremide lipid species were decreased and other metabolites, such as thiophene-3-carboxylate and benzothiazine-2-carbonitrile, were increased at both PN7 and PN28. Further numerous lipid compounds were identified only within cystic fluid that have not been previously annotated. Conclusions: The results of this study, for the first time, reveals alterations in lipid molecule profiles throughout the cystic kidney in tandem with morphological changes. This is a major step forward in understanding how lipid metabolism changes in response to cyst expansion during the progression of ADPKD, as well as revealing molecular changes that precede cellular pathology. This work has been supported by Children’s Wisconsin Foundation and Children’s Research Institute. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Blood pressure (BP)-relevant non-coding SNPs identified by GWAS may influence the expression of distal protein-coding genes. Our previous study detected 195 SNPs (out of 26585) in CTCF-binding sites. CTCF and Cohesin are known to modulate cell-type-specific gene expression from a distance by forming chromatin loops. We hypothesized that both may regulate gene expression in BP-relevant cell types. To test this, we depleted CTCF and Rad21 (Cohesin subunit) in human induced pluripotent stem cells-derived endothelial cells (iEC) and performed genome-wide transcriptomic analysis. We detected 366 and 4184 differentially expressed genes (DEGs) in CTCF and Rad21 depleted iEC (CTCF-/Rad21-KD-iEC) compared to iEC control, respectively. Among them, 111 DEGs are common between the CTCF-KD and Rad21-KD-iEC, though majority showed opposite regulatory effects (Figure 1A). We found 5619 DEGs in the CTCF-KD vs Rad21-KD-iEC (Figure 1B). Pathway analysis detected elevated cell cycle (G2M checkpoint), DNA replication (E2F targets), and repair pathways in Rad21-KD compared to the CTCF-KD-iEC. Rad21 plays an important role in chromosome partitioning and repair, so its depletion may cause dysregulation of these pathways. While the CTCF-KD-iEC showed enrichment of the Epithelial-to-mesenchymal transition (EMT), inflammatory (IFN-gamma, IFN-alpha), and hypoxia pathways (Figure 1C). As CTCF maintains the chromosome boundaries, CTCF-KD may affect chromatin compactness and trigger abnormal gene expression related to these pathways. In conclusion, our study detected different effects of depletion of CTCF and Rad21 on gene expression in a BP-relevant cell type. The findings provide a basis to explore the role of chromatin looping in BP-relevant gene regulation.

Most SNPs associated with blood pressure (BP) are located in noncoding regions of the human genome, where they may regulate gene expression in BP-relevant cell types. However, the mechanisms by which these SNPs influence BP regulation are unclear. To address this, we developed comprehensive epigenomic landscapes in human induced pluripotent stem cell (iPSC)-derived endothelial cells (iECs) and vascular smooth muscle cells (iVSMCs), incorporating DNA methylation analysis (RRBS), transcriptome analysis (RNA-seq), chromatin state profiling (ATAC-seq), and chromatin interaction mapping (Micro-C). We identified 5301, 8916, and 6046 chromatin loops in iECs and 5329, 7598, and 5228 loops in iVSMCs at 4, 8, and 16 kb resolutions (FDR < 0.05) respectively based on the Micro-C analysis. Remarkably, 82.4% and 83.8% of these chromatin contact regions in iECs and iVSMCs, respectively, harbored at least one known regulatory element such as an enhancer, promoter, or transcription factor binding site. Notably, 109 and 119 BP-associated SNPs were found within the chromatin contact regions of iECs and iVSMCs, respectively. We further investigated chromatin contact regions that involved interactions of regulatory elements. In both iECs and iVSMCs, lower methylation levels were observed in chromatin contact regions involving promoter-promoter (PP) and enhancer-promoter (EP) interactions, compared to enhancer-enhancer (EE), enhancer-transcription factor binding site (ET), and promoter-transcription factor binding site (PT) interactions. Additionally, greater chromatin accessibility was observed in chromatin contact regions involving PP and EP interactions. BP-associated SNPs were significantly enriched in chromatin contact regions involving PP and EP interactions. Moreover, genes proximal to chromatin contact regions involving PP or EP interactions exhibited higher expression than those near EE or other regulatory element interactions. These findings offer new insights into how chromatin interactions between regulatory elements define transcriptional states in human endothelial and vascular smooth muscle cells, providing a novel basis for understanding the genetic regulation of BP.

Resistance arteries, or arterioles, are key determinants of the total peripheral vascular resistance, which, in turn, is a key determinant of arterial blood pressure (BP). However, the amount of protein available from one isolated human arteriole may be less than 5 μg, making proteomic analysis challenging. In addition, obtaining human arterioles requires manual dissection of unfrozen clinical specimens. This limits its feasibility, especially for powerful multi-center clinical studies in which clinical specimens need to be shipped overnight to a research lab for arteriole isolation. We performed a study to address low input, test overnight tissue storage, and develop a reference human arteriolar proteomic profile. We found that, in tandem mass tag proteomic analysis, the use of a booster channel consisting of endothelial and vascular smooth muscle cells (1:5 ratio) increased the number of proteins detected in a human arteriole segment with FDR < 0.01 from 1,051 to more than 3,000. We collected adipose tissues from three human subjects and isolated two arterioles from each fresh aliquot of the tissue or after 24h of cold storage of unfrozen aliquots in MACS tissue solution. The correlation coefficient of proteomic profile was similar (p=0.6) between replicate arterioles isolated freshly, following the cold storage, or before and after the cold storage. We built a human arteriolar proteomic profile consisting of 3,836 proteins based on the analysis of 12 arteriole samples from the three subjects. The average arteriolar protein had a mean copy number of 2.76х10 6 per cell using the histone proteomic ruler, which is based on the fact that the mass of DNA per cell is approximately equal to the protein mass of histones. Transgelin was the most abundant protein detected. We curated a set of BP-relevant human genes, which encode 1,945 proteins. Of these BP-relevant proteins, 476 (12.5%) were detected in the arteriolar proteome, which was a significant overrepresentation (p<0.05, Chi squared test). These findings demonstrate that proteomic analysis is feasible with arterioles isolated from human adipose tissue following cold overnight storage and provide a reference human arteriolar proteome profile highly valuable for studies of arteriole-related traits.

Hypertension is a leading risk factor for disease burden and death worldwide. Several organ systems are involved in the development of hypertension, which contributes to stroke, heart disease, and kidney disease. Despite the broad health relevance, our understanding of the molecular landscape in hypertension is limited and lags other major diseases. Here we report an extensive analysis of the molecular landscape in hypertension and its end-organ damage and uncover novel mechanisms linking human genetic variants to the development of these diseases. We obtained single-nucleus RNA-seq (612,984 nuclei), single-nucleus ATAC-seq (179,637 nuclei), or spatial transcriptome data from five organs (hypothalamus, kidney, heart, 3rd order mesenteric artery, middle cerebral artery) in three mouse and rat models under twelve experimental conditions. More than one third of all hypertension research in animal models involves these three models. We identified both model-specific and convergent responses in cell types, genes, and pathways. By integrating our data with human genomic data, we partitioned the blood pressure and end-organ damage traits into cell type-specific transcriptional contributions and cell types common across multiple traits. Using genomic editing in animal models and human induced pluripotent stem cells, we extended key findings and identified new mechanisms linking human genetic variants to the development of hypertension and related renal injury. We anticipate that our rich data sets and findings will broadly drive forward the research of hypertension and hypertensive end-organ damage. Our approach of integrating multi-model and multi-tissue single-cell analysis with human genetic data and in vivo and in vitro genome editing can be applied to investigate other complex traits. ### Competing Interest Statement The authors have declared no competing interest.

Hypertension is the leading risk factor for cardiovascular disease and impacts one in three adults globally. One non-coding mechanism that may affect blood pressure regulation and alter hypertension risk in the general population is the disruption of chromatin conformation. CCCTCF-binding factor (CTCF) has many important functions including regulating the conformation of chromatin by binding to specific DNA sequences. Renin has multiple CTCF motifs surrounding the gene and cellular expression of CTCF is critical for proper Renin expression. Using CRISPR-Cas9 in the Dahl salt-sensitive (SS) rat, we have developed three mutant rat models with one or more mutations to the CTCF motif surrounding the Renin gene. CTCF binding was confirmed to be disrupted in all three models at the CRISPR-targeted locations. Plasma renin activity (PRA) was measured in wild-type (WT) and mutant rats fed a 0.1%, 0.4% or 4.0% NaCl diet for four days. PRA in WT males responded as expected to dietary NaCl (17.52±0.81, 12.87±1.00, and 7.13±0.19 ng/mL; p<0.05 for 0.1% and 4.0% vs. 0.4%). Interestingly, two of our male mutant models failed to increase their PRA on the 0.1% NaCl diet (CTCF1=13.87±0.86; CTCF2=13.95±0.59; p<0.05 compared to WT 0.1% NaCl). Despite this, no differences in Renin mRNA were detected. We hypothesize Renin transcriptional response to salt depletion is delayed in the mutant models compared to WT. To test this, we developed an ex vivo approach to culture kidney slices and evaluate Renin expression to a variety of stimuli. Kidneys from SS rats fed low salt (LS; 0.4% NaCl) or high salt (HS) diet (4.0% NaCl) for 24 hours were harvested, sliced, and cultured in basal media or media containing increasing salt. Renin expression was examined at 1, 2, 4, 8 and 24 hrs of incubation. Kidney slices from SS rats fed HS that were incubated basal media stimulated Renin expression as soon as 2 hrs and continued to increase until 8 hrs. This was the first time for establishing an ex vivo approach for motoring the dynamic changes in Renin expression in response to a stimulus by culturing kidney slices. This method could be used to evaluate other stimuli, such as therapeutics, and could decrease the number of animals needed for a study. Funded by NIH 1HL149620. This is the full abstract presented at the American Physiology Summit 2024 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

BACKGROUND: Hypertension or elevated blood pressure (BP) is a worldwide clinical challenge and the leading primary risk factor for kidney dysfunctions, heart failure, and cerebrovascular disease. The kidney is a central regulator of BP by maintaining sodium-water balance. Multiple genome-wide association studies revealed that BP is a heritable quantitative trait, modulated by several genetic, epigenetic, and environmental factors. The SNPs identified in genome-wide association studies predominantly (>95%) reside within noncoding genomic regions, making it difficult to understand how they regulate BP. Given the central role of the kidney in regulating BP, we hypothesized that chromatin-accessible regions in renal tissue would be enriched for BP-associated single nucleotide polymorphisms. METHODS: We manually dissected 2 important kidney segments that maintain the sodium-water balance: proximal tubules and medullary thick ascending limbs from the human and rat kidneys. To delineate their chromatin and transcriptomic profiles, we performed the assay for transposase-accessible chromatin and RNA sequencing, respectively. RESULTS: The chromatin accessibility maps revealed the shared and unique cis -regulatory elements that modulate the chromatin accessibility in proximal tubule and medullary thick ascending limbs of humans and rats. We developed a visualization tool to compare the cross-species epigenomic maps to identify potential regulatory targets for hypertension pathogenesis. We also identified a significant enrichment of BP-associated single nucleotide polymorphisms (1064 for human proximal tubule and 1172 for human medullary thick ascending limbs) within accessible chromatin regions of both segments, including rs1173771 and rs1421811 at the NPR3 locus and rs1800470 at the TGFb1 locus. CONCLUSIONS: Collectively, this study lays a foundation for interrogating how intergenic single nucleotide polymorphisms may regulate polygenic traits such as BP.

Transcriptomic and proteomic approaches have identified electrolyte transporters, channels and claudins with sex-specific expression along the nephron which adapt to physiological stressors in a sex-specific manner to maintain proper fluid and electrolyte homeostasis. Yet, less is known how long non-coding gene expression in specific nephron segments differs between sexes. We performed polyA-independent RNA-seq on manually isolated proximal tubule (PT) and medullary thick ascending limb (mTAL) from 6-7-week-old male and female Dahl salt sensitive rats. Sex specific gene expression differences [log2(fold change) ≥ 0.5 or ≤ -0.5; p adj ≤ 0.05] are summarized in the table. More sex-specific differences of both protein coding and lncRNA genes were detected in PT compared to mTAL. lncRNAs were less likely to demonstrate sex-specific differences than protein coding genes (p=2.59e-12 for PT and p=5.68e-3 for mTAL). Rare lncRNAs were expressed in one sex or the other (sex-exclusive). An interesting example is ENSRNOG00000069167 and ENSRNOG00000063718 which are transcribed on opposite strands from an overlapping sequence in male or female mTAL, respectively. Multiple sex-exclusive lncRNAs were colocalized with protein coding genes significantly enriched in the same sex, suggesting they may be co-regulated within a specific chromatin domain. For example, ENSRNOG00000068738 was exclusively expressed in male PT and is colocalized in a ~560-kbp region with Pcnx1 and Sipa1l1, both of which were also enriched in male PT. Collectively, these results extend our understanding of sex-specific gene expression differences in these nephron segments to include long non-coding genes.

The hypothalamus plays a key role in blood pressure regulation through coordinating and integrating signals in the central nervous system. However, it’s remains underexplored how the cell signaling network in the hypothalamus changes during the progression of hypertension, the key regulators involved, and whether shared or distinct pathophysiological mechanisms underlie the development of hypertension triggered by various genetic susceptibility or environmental factors. To address these questions, we applied the single-nucleus RNA sequencing technology to analyze hypothalamus samples from three well-established models of hypertension with distinct pathogenesis - mice treated with Ang II, the Dahl salt-sensitive rat, and the spontaneous hypertensive rat - along with their respective controls. Data were obtained from 238,445 nuclei from 24 samples under 12 experimental conditions. By characterizing the cellular composition under different disease conditions, we discovered an elevated glia-to-neuron ratio in Ang II-induced hypertension, with increases of 3.1-fold in astrocytes, 4.0-fold in microglia, and 3.4-fold in oligodendrocytes. Moreover, astrocytes underwent a transition from the resting state to a reactive mode associated with neuroinflammation and stronger neuron adhesion. Additionally, multiple neuronal signal communication pathways were overactivated in response to Ang II, including neurexin-neuroligin signaling, nitric oxide-guanylate cyclase pathway, and glutamate and its receptors. In the salt-sensitive hypertension, a 2.3-fold expansion of pro-inflammatory microglia via Cd74 activation was observed after a short-term high-sodium diet, which leveled off thereafter. With a prolonged high-salt intake, there was a 1.7-fold increase in the proportion of Plagl1+ GABA-ergic neurons. In 26 weeks old spontaneously hypertensive rats, a distinctive 1.4-fold increase in the proportion of Slit3+ Glu-ergic neurons was observed, setting them apart from WKY rats. These findings provide new insights into how the hypothalamus may be involved in the development of hypertension under different disease conditions.

Introduction:Congenital heart disease is the leading cause of death related to birth defects and affects 1 out of every 100 live births. Induced pluripotent stem cell technology has allowed for patient-derived cardiomyocytes to be studied in vitro. An approach to bioengineer these cells into a physiologically accurate cardiac tissue model is needed in order to study the disease and evaluate potential treatment strategies.Methods:To accomplish this, we have developed a protocol to 3D-bioprint cardiac tissue constructs comprised of patient-derived cardiomyocytes within a hydrogel bioink based on laminin-521.Results:Cardiomyocytes remained viable and demonstrated appropriate phenotype and function including spontaneous contraction. Contraction remained consistent during 30 days of culture based on displacement measurements. Furthermore, tissue constructs demonstrated progressive maturation based on sarcomere structure and gene expression analysis. Gene expression analysis also revealed enhanced maturation in 3D constructs compared to 2D cell culture.Discussion:This combination of patient-derived cardiomyocytes and 3D-bioprinting represents a promising platform for studying congenital heart disease and evaluating individualized treatment strategies.

Abstract Our current understanding of the relationship between estrogen and human endothelial colony‐forming cell (hECFC) function is based almost exclusively on studies investigating estradiol action at nuclear estrogen receptors. In the current study the hypothesis was tested that the less potent estrogen receptor agonist, estrone, affects hECFC proliferation, migration, secretion, and tube formation in a way that is unique from that of estradiol. The relationship between the estrogens, estradiol and estrone, is clinically important, particularly in postmenopausal women where estradiol levels wane and estrone becomes the predominant estrogen. Cultured hECFCs from peripheral blood mononuclear cell fractions were treated with concentrations of estradiol and estrone ranging from 1 nM to 1 μM separately and in combination. Following treatment, proliferation, migration, ability to attract other hECFCs (autocrine secretion), and ability to enhance endothelial cell tube formation (tubulogenesis) were tested. Functional assays revealed unique, concentration‐dependent physiological effects of estrone and estradiol. Estradiol exposure resulted in increased hECFC proliferation, migration, secretion of chemoattractant, and enhancement of tube formation as expected. As with estradiol, hECFC secretion of chemoattractant increased significantly with each increase in estrone exposure. Estrone treatment produced a biphasic, concentration‐dependent relationship with proliferation and tube formation and relatively no effect on hECFC migration at any concentration. The quantitative relationship between the effects of estrone and estradiol and each hECFC function was analyzed. The extent to which estrone was similar in effect to that of estradiol was dependent on both the concentrations of estradiol and estrone and the hECFC function measured. Interestingly, when the two estrogens were present, differing ratios resulted in unique functional responses. hECFCs that were treated with combinations of estrone and estradiol with high estrone to estradiol ratios showed decreased proliferative capacity. Conversely, hECFCs that were treated with combinations that were relatively high in estradiol, showed increased proliferative capacity. Cells that were treated with estrone and estradiol in equal concentrations showed an attenuated proliferative response that was decreased compared to the proliferation that either estrone or estradiol produced when they were present alone. This co‐inhibitory relationship, which has not been previously reported, challenges the prevailing understanding of estrone as solely a weak agonist at estrogen receptors. This study provides evidence that estrone signaling is distinct from that of estradiol and that further investigation of estrone's mechanism of action and the biological effect may provide important insight into understanding the dysfunction and decreased number of hECFCs, and the resulting cardiovascular disease risk observed clinically in menopausal women and women undergoing hormone replacement therapy.